Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Bei Qing

3PUBLICATIONS
3CO-AUTHORS
Metabolic medicineMolecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Dec 23, 2022
A Comprehensive Mass Spectrometry-Based Workflow for Clinical Metabolomics Cohort Studies.

Zhan Shi, Haohui Li, Wei Zhang

|Sep 23, 2022
<i>NCAPG2</i> Maintains Cancer Stemness and Promotes Erlotinib Resistance in Lung Adenocarcinoma.

Shiyao Jiang, Jingjing Huang, Hua He

|Nov 04, 2021
Formation, contents, functions of exosomes and their potential in lung cancer diagnostics and therapeutics.

Zhenkun Xia, Bei Qing, Wei Wang

Pageof 1

Frequent Collaborators

1 joint publications

Zhenkun Xia

1 joint publications

Yiqun Jiang

1 joint publications

Xinping Xu

Frequent Collaborators

1 joint publications

Zhenkun Xia

1 joint publications

Yiqun Jiang

1 joint publications

Xinping Xu

Top Related Videos

An Integrated Workflow of Identification and Quantification on FDR Control-Based Untargeted Metabolome
05:35

An Integrated Workflow of Identification and Quantification on FDR Control-Based Untargeted Metabolome

Published on : Sep 20, 2022

3.8K
Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on : Jun 26, 2019

8.0K
Using Nanoplasmon-Enhanced Scattering and Low-Magnification Microscope Imaging to Quantify Tumor-Derived Exosomes
09:30

Using Nanoplasmon-Enhanced Scattering and Low-Magnification Microscope Imaging to Quantify Tumor-Derived Exosomes

Published on : May 24, 2019

7.5K
See more related videos

Top Related Videos

An Integrated Workflow of Identification and Quantification on FDR Control-Based Untargeted Metabolome
05:35

An Integrated Workflow of Identification and Quantification on FDR Control-Based Untargeted Metabolome

Published on : Sep 20, 2022

3.8K
Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on : Jun 26, 2019

8.0K
Using Nanoplasmon-Enhanced Scattering and Low-Magnification Microscope Imaging to Quantify Tumor-Derived Exosomes
09:30

Using Nanoplasmon-Enhanced Scattering and Low-Magnification Microscope Imaging to Quantify Tumor-Derived Exosomes

Published on : May 24, 2019

7.5K
See more related videos